DekaBank Deutsche Girozentrale’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $158M | Hold |
211,207
| – | – | 0.27% | 86 |
|
|
2026
Q1 | $161M | Hold |
211,207
| – | – | 0.27% | 86 |
|
|
2025
Q4 | $207M | Hold |
211,207
| – | – | 0.36% | 62 |
|
|
2025
Q3 | $118M | Hold |
211,207
| – | – | 0.2% | 118 |
|
|
2025
Q2 | $110M | Sell |
211,207
-9,969
| -5% | -$5.56M | 0.2% | 122 |
|
|
2025
Q1 | $139M | Buy |
221,176
+9,969
| +5% | +$6.86M | 0.27% | 88 |
|
|
2024
Q4 | $148M | Hold |
211,207
| – | – | 0.27% | 86 |
|
|
2024
Q3 | $219M | Sell |
211,207
-2,617
| -1% | -$2.91M | 0.41% | 60 |
|
|
2024
Q2 | $224M | Sell |
213,824
-7,352
| -3% | -$7.13M | 0.4% | 55 |
|
|
2024
Q1 | $213M | Sell |
221,176
-3,009
| -1% | -$2.86M | 0.4% | 56 |
|
|
2023
Q4 | $196M | Buy |
224,185
+23,795
| +12% | +$19.6M | 0.4% | 55 |
|
|
2023
Q3 | $167M | Buy |
200,390
+32,538
| +19% | +$25.6M | 0.38% | 54 |
|
|
2023
Q2 | $119M | Sell |
167,852
-5,839
| -3% | -$4.5M | 0.27% | 90 |
|
|
2023
Q1 | $140M | Buy |
173,691
+2,702
| +2% | +$2.04M | 0.35% | 66 |
|
|
2022
Q4 | $122M | Sell |
170,989
-7,881
| -4% | -$5.82M | 0.32% | 78 |
|
|
2022
Q3 | $123M | Buy |
178,870
+7,656
| +4% | +$4.82M | 0.36% | 63 |
|
|
2022
Q2 | $102M | Buy |
171,214
+20,227
| +13% | +$13.1M | 0.3% | 83 |
|
|
2022
Q1 | $106M | Buy |
150,987
+45,440
| +43% | +$28.7M | 0.26% | 96 |
|
|
2021
Q4 | $68.2M | Buy |
105,547
+9,029
| +9% | +$5.55M | 0.17% | 140 |
|
|
2021
Q3 | $59.1M | Buy |
96,518
+12,787
| +15% | +$7.94M | 0.17% | 145 |
|
|
2021
Q2 | $45.7M | Buy |
83,731
+4,819
| +6% | +$2.44M | 0.13% | 169 |
|
|
2021
Q1 | $37.1M | Buy |
78,912
+18,627
| +31% | +$9.07M | 0.12% | 175 |
|
|
2020
Q4 | $29.3M | Buy |
60,285
+10,908
| +22% | +$5.89M | 0.11% | 189 |
|
|
2020
Q3 | $29.3M | Buy |
49,377
+36,266
| +277% | +$22M | 0.13% | 155 |
|
|
2020
Q2 | $8.03M | Buy |
13,111
+1,570
| +14% | +$891K | 0.05% | 238 |
|
|
2020
Q1 | $5.56M | Buy |
11,541
+44
| +0.4% | +$18.1K | 0.04% | 261 |
|
|
2019
Q4 | $4.27M | Sell |
11,497
-37,530
| -77% | -$12.6M | 0.03% | 368 |
|
|
2019
Q3 | $13.5M | Sell |
49,027
-10,645
| -18% | -$3.15M | 0.08% | 214 |
|
|
2019
Q2 | $18.6M | Buy |
59,672
+12,494
| +26% | +$4.16M | 0.09% | 232 |
|
|
2019
Q1 | $19.4M | Buy |
47,178
+8,195
| +21% | +$3.37M | 0.12% | 196 |
|
|
2018
Q4 | $14.3M | Sell |
38,983
-8,195
| -17% | -$3M | 0.09% | 213 |
|
|
2018
Q3 | $19.4M | Sell |
47,178
-14,951
| -24% | -$5.69M | 0.11% | 198 |
|
|
2018
Q2 | $21.3M | Buy |
62,129
+14,995
| +32% | +$4.69M | 0.14% | 180 |
|
|
2018
Q1 | $16.1M | Sell |
47,134
-23,435
| -33% | -$8.15M | 0.11% | 202 |
|
|
2017
Q4 | $33.2M | Buy |
70,569
+450
| +0.6% | +$182K | 0.26% | 94 |
|
|
2017
Q3 | $33M | Sell |
70,119
-5,056
| -7% | -$2.41M | 0.26% | 95 |
|
|
2017
Q2 | $38.4M | Buy |
75,175
+6,028
| +9% | +$2.64M | 0.31% | 84 |
|
|
2017
Q1 | $26.8M | Buy |
69,147
+547
| +0.8% | +$203K | 0.25% | 95 |
|
|
2016
Q4 | $26M | Buy |
68,600
+2,287
| +3% | +$870K | 0.28% | 86 |
|
|
2016
Q3 | $26.9M | Buy |
66,313
+1,794
| +3% | +$720K | 0.3% | 81 |
|
|
2016
Q2 | $22.4M | Buy |
64,519
+97
| +0.2% | +$37.4K | 0.26% | 91 |
|
|
2016
Q1 | $23.2M | Sell |
64,422
-6,726
| -9% | -$2.77M | 0.27% | 86 |
|
|
2015
Q4 | $39M | Sell |
71,148
-79
| -0.1% | -$42.8K | 0.45% | 53 |
|
|
2015
Q3 | $33.1M | Buy |
71,227
+5,984
| +9% | +$3.21M | 0.4% | 52 |
|
|
2015
Q2 | $33.3M | Buy |
65,243
+785
| +1% | +$383K | 0.39% | 56 |
|
|
2015
Q1 | $29.1M | Sell |
64,458
-2,680
| -4% | -$1.14M | 0.36% | 59 |
|
|
2014
Q4 | $27.8M | Sell |
67,138
-3,070
| -4% | -$1.21M | 0.35% | 60 |
|
|
2014
Q3 | $25M | Buy |
70,208
+23,958
| +52% | +$8.03M | 0.34% | 63 |
|
|
2014
Q2 | $12.8M | Sell |
46,250
-22,849
| -33% | -$6.77M | 0.19% | 123 |
|
|
2014
Q1 | $20.9M | Buy |
69,099
+1,960
| +3% | +$604K | 0.33% | 66 |
|
|
2013
Q4 | $18.5M | Buy |
67,139
+8,519
| +15% | +$2.45M | 0.3% | 69 |
|
|
2013
Q3 | $17.7M | Buy |
58,620
+1,948
| +3% | +$512K | 0.31% | 66 |
|
|
2013
Q2 | $13.2M | Buy |
+56,672
| New | +$13.2M | 0.26% | 80 |
|
Other funds holding REGN
DekaBank Deutsche Girozentrale's REGN Position: Q2 2026 in Review
DekaBank Deutsche Girozentrale held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 211,207 shares worth $158M. The position accounts for 0.27% of the portfolio, ranked #86.
DekaBank Deutsche Girozentrale first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $224M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- DekaBank Deutsche Girozentrale held 211,207 shares of Regeneron Pharmaceuticals worth $158M as of Q2 2026.
- DekaBank Deutsche Girozentrale left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up 0.27% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #86 holding.
- DekaBank Deutsche Girozentrale first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- DekaBank Deutsche Girozentrale's Regeneron Pharmaceuticals position peaked at $224M in Q2 2024.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.